Quinidine sulfate administration for intractable epilepsy with KCNT1 gene mutatio
Not Applicable
- Conditions
- Intractable epilepsy with KCNT1 gene mutation
- Registration Number
- JPRN-UMIN000019594
- Lead Sponsor
- HO, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
The patient who is judged by the patient's physician as unsuitable for participating in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in frequency of epileptic seizures
- Secondary Outcome Measures
Name Time Method Change in severity of epileptic seizures. Change in EEG finding. Change in psychomotor development.